Pneumococcal polysaccharide serotype conjugated crm197
VAXNEUVANCE® Suspension for Injection
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Sciences Authority / data.gov.sg
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pneumococcal polysaccharide serotype conjugated crm197
- Strength
- 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 2μg + 4μg + 2μg + 2μg
- Dosage form
- injection, suspension
- Route
- intramuscular
- Register
- Singapore (HSA)
- Status
- Authorised
- Status in the register
- Registered
- Authorised
- 7 Feb 2024
- Registration
- SIN16944P